Kazinol C from Broussonetia kazinoki activates AMP-activated protein kinase to induce antitumorigenic effects in HT-29 colon cancer cells

Oncology Reports

Volumn 33, Issue 1, 2015, Pages 223-229

  Kim, Hak Su ^a   Lim, Jihyun ^a   Lee, Da Yeon ^a   Ryu, Jae Ha ^a   Lim, Jong Seok ^a  

^a Sookmyung Women's University   (South Korea)

Author keywords

AMP activated protein kinase; Apoptosis; Colon cancer; Kazinol C; Migration

Indexed keywords

ANTINEOPLASTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; KAZINOL C; UNCLASSIFIED DRUG; ADENYLATE KINASE; ENZYME ACTIVATOR; HEMITERPENE; HERBACEOUS AGENT; RESORCINOL DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BARK; BROUSSONETIA KAZINOKI; CANCER GROWTH; CELL ANCHORAGE; CELL MIGRATION; CELL VIABILITY; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVATION; HT 29 CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; PLANT ROOT; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; BROUSSONETIA; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; METABOLISM;

ADENYLATE KINASE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BROUSSONETIA; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; DRUG SCREENING ASSAYS, ANTITUMOR; DRUGS, CHINESE HERBAL; ENZYME ACTIVATION; ENZYME ACTIVATORS; HEMITERPENES; HT29 CELLS; HUMANS; RESORCINOLS;

EID: 84916212079     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3601     Document Type: Article

References (35)

1. Hardie DG, Carling D and Carlson M: The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 67: 821-855, 1998.
2. Hardie DG and Alessi DR: LKB1 and AMPK and the cancermetabolism link-ten years after. BMC Biol 11: 36, 2013.
3. Shackelford DB and Shaw RJ: The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer 9: 563-575, 2009.
4. Inoki K, Ouyang H, Zhu T, Lindvall C, Wang Y, Zhang X, Yang Q, Bennett C, Harada Y, Stankunas K, Wang CY, He X, MacDougald OA, You M, Williams BO and Guan KL: TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 126: 955-968, 2006.
5. Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, Birnbaum MJ and Thompson CB: AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 18: 283-293, 2005.
6. Hwang JT, Kim YM, Surh YJ, Baik HW, Lee SK, Ha J and Park OJ: Selenium regulates cyclooxygenase-2 and extracellular signal-regulated kinase signaling pathways by activating AMP-activated protein kinase in colon cancer cells. Cancer Res 66: 10057-10063, 2006.
7. Mihaylova MM and Shaw RJ: The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 13: 1016-1023, 2011.
8. Sanli T, Steinberg GR, Singh G and Tsakiridis T: AMP-activated protein kinase (AMPK) beyond metabolism: a novel genomic stress sensor participating in the DNA damage response pathway. Cancer Biol Ther 15: 156-169, 2014.
9. Kim HS, Kim MJ, Kim EJ, Yang Y, Lee MS and Lim JS: Berberineinduced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression. Biochem Pharmacol 83: 385-394, 2012.
10. Nakano A, Kato H, Watanabe T, Min KD, Yamazaki S, Asano Y, Seguchi O, Higo S, Shintani Y, Asanuma H, Asakura M, Minamino T, Kaibuchi K, Mochizuki N, Kitakaze M and Takashima S: AMPK controls the speed of microtubule polymerization and directional cell migration through CLIP-170 phosphorylation. Nat Cell Biol 12: 583-590, 2010.
11. Taliaferro-Smith L, Nagalingam A, Zhong D, Zhou W, Saxena NK and Sharma D: LKB1 is required for adiponectinmediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells. Oncogene 28: 2621-2633, 2009.
12. Kim AY, Lee CG, Lee da Y, Li H, Jeon R, Ryu JH and Kim SG: Enhanced antioxidant effect of prenylated polyphenols as Fyn inhibitor. Free Radic Biol Med 53: 1198-1208, 2012.
13. Ko HH, Yen MH, Wu RR, Won SJ and Lin CN: Cytotoxic isoprenylated flavans of Broussonetia kazinoki. J Nat Prod 62: 164-166, 1999.
14. Cha JY, Kim YT, Kim HS and Cho YS: Antihyperglycemic effect of stem bark powder from paper mulberry (Broussonetia kazinoki Sieb.) in type 2 diabetic Otsuka Long-Evans Tokushima fatty rats. J Med Food 11: 499-505, 2008.
15. Baek YS, Ryu YB, Curtis-Long MJ, Ha TJ, Rengasamy R, Yang MS and Park KH: Tyrosinase inhibitory effects of 1,3-diphenylpropanes from Broussonetia kazinoki. Bioorg Med Chem 17: 35-41, 2009.
16. Lee DY, Kim DH, Lee HJ, Lee Y, Ryu KH, Jung BI, Song YS and Ryu JH: New estrogenic compounds isolated from Broussonetia kazinoki. Bioorg Med Chem Lett 20: 3764-3767, 2010.
17. Ikuta J, Hano Y, Nomura T, Kawakami Y and Sato T: Components of Broussonetia kazinoki SIEB. I. Structures of two new isoprenylated flavans and five new isoprenylated 1,3-diphenylpropane derivatives. Chem Pharm Bull 34: 1968-1979, 1986.
18. Woods A, Azzout-Marniche D, Foretz M, Stein SC, Lemarchand P, Ferré P, Foufelle F and Carling D: Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Mol Cell Biol 20: 6704-6711, 2000.
19. Wang W and Guan KL: AMP-activated protein kinase and cancer. Acta Physiol 196: 55-63, 2009.
20. Jang T, Calaoagan JM, Kwon E, Samuelsson S, Recht L and Laderoute KR: 5′-AMP-activated protein kinase activity is elevated early during primary brain tumor development in the rat. Int J Cancer 128: 2230-2239, 2011.
21. Yun H, Kim HS, Lee S, Kang I, Kim SS, Choe W and Ha J: AMP kinase signaling determines whether c-Jun N-terminal kinase promotes survival or apoptosis during glucose deprivation. Carcinogenesis 30: 529-537, 2009.
22. Kim HS, Wannatung T, Lee S, Yang WK, Chung SH, Lim JS, Choe W, Kang I, Kim SS and Ha J: Quercetin enhances hypoxiamediated apoptosis via direct inhibition of AMPK activity in HCT116 colon cancer. Apoptosis 17: 938-949, 2012.
23. Tseng CH: Diabetes, metformin use, and colon cancer: a population-based cohort study in Taiwan. Eur J Endocrinol 167: 409-416, 2012.
24. Din FV, Valanciute A, Houde VP, Zibrova D, Green KA, Sakamoto K, Alessi DR and Dunlop MG: Aspirin inhibits mTOR signaling, activates AMP-activated protein kinase, and induces autophagy in colorectal cancer cells. Gastroenterology 142: 1504-1515.e3, 2012.
25. Hawley SA, Fullerton MD, Ross FA, Schertzer JD, Chevtzoff C, Walker KJ, Peggie MW, Zibrova D, Green KA, Mustard KJ, Kemp BE, Sakamoto K, Steinberg GR and Hardie DG: The ancient drug salicylate directly activates AMP-activated protein kinase. Science 336: 918-922, 2012.
26. O'Neill LA and Hardie DG: Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 493: 346-355, 2013.
27. Lee YK and Park OJ: Regulation of mutual inhibitory activities between AMPK and Akt with quercetin in MCF-7 breast cancer cells. Oncol Rep 24: 1493-1497, 2010.
28. Yang X and Huang N: Berberine induces selective apoptosis through the AMPK-mediated mitochondrial/caspase pathway in hepatocellular carcinoma. Mol Med Rep 8: 505-510, 2013.
29. Puissant A, Robert G, Fenouille N, Luciano F, Cassuto JP, Raynaud S and Auberger P: Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation. Cancer Res 70: 1042-1052, 2010.
30. Kim EK, Park JM, Lim S, Choi JW, Kim HS, Seok H, Seo JK, Oh K, Lee DS, Kim KT, Ryu SH and Suh PG: Activation of AMP-activated protein kinase is essential for lysophosphatidic acid-induced cell migration in ovarian cancer cells. J Biol Chem 286: 24036-24045, 2011.
31. Frigo DE, Howe MK, Wittmann BM, Brunner AM, Cushman I, Wang Q, Brown M, Means AR and McDonnell DP: CaM kinase kinase β-mediated activation of the growth regulatory kinase AMPK is required for androgen-dependent migration of prostate cancer cells. Cancer Res 71: 528-537, 2011.
32. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, Funahashi T and Walsh K: Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 279: 1304-1309, 2004.
33. Martinelli R, Gegg M, Longbottom R, Adamson P, Turowski P and Greenwood J: ICAM-1-mediated endothelial nitric oxide synthase activation via calcium and AMP-activated protein kinase is required for transendothelial lymphocyte migration. Mol Biol Cell 20: 995-1005, 2009.
34. Park JJ, Seo SM, Kim EJ, Lee YJ, Ko YG, Ha J and Lee M: Berberine inhibits human colon cancer cell migration via AMP-activated protein kinase-mediated downregulation of integrin β1 signaling. Biochem Biophys Res Commun 426: 461-467, 2012.
35. Peyton KJ, Yu Y, Yates B, Shebib AR, Liu XM, Wang H and Durante W: Compound C inhibits vascular smooth muscle cell proliferation and migration in an AMP-activated protein kinase-independent fashion. J Pharmacol Exp Ther 338: 476-484, 2011.